Results 101 to 110 of about 2,071 (176)

Bimekizumab: The First FDA-Approved Dual IL-17A/IL-17F Inhibitor for Plaque Psoriasis – A Comprehensive Literature Review

Psoriasis: Targets and Therapy
Sukainah Ahmed Al Alshaikh, Zahra Mohammad Almarhoon, Hisham Momattin, Mahdi Aleid, Zahra H Almousa, Ali Kamal Alqaisum, Fatimah Ismail Mobarki, Sarah Aon Almakki, Hamzah Alturfi, Kouther Jamil Almajed Department of Pharmacy, Mouwasat Hospital, Dammam ...
Al Alshaikh SA, Almarhoon ZM, Momattin H, Aleid M, Almousa ZH, Alqaisum AK, Mobarki FI, Almakki SA, Alturfi H, Almajed KJ   +9 more
doaj  

Real-life effectiveness and safety of bimekizumab in patients with moderate plaque psoriasis: a 54-week multicentre study in the Lazio region. [PDF]

Drugs Context
Feresin F, Bernardini N, Campione E, Caldarola G, Gubinelli E, Moretta G, Pagnanelli G, Giordano D, Persechino S, Falco GM, Artosi F, Zappia E, Pellacani G, Potenza C, Richetta AG, De Simone C, Orsini D, Dattola A.   +17 more
europepmc   +1 more source

The IL-23/-17 Axis in PsA: What Have We Learned in the Last 20 Years? [PDF]

Mediterr J Rheumatol
Theodoridou F, Katsouli O, Fragoulis GE.
europepmc   +1 more source

Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extension. [PDF]

RMD Open
Navarro-Compán V, Kiltz U, Mease PJ, Dubreuil M, Gaffney K, Deodhar A, de la Loge C, Prajapati C, Kavanagh S, Marzo-Ortega H.   +9 more
europepmc   +1 more source

Real-world single-centre experience of bimekizumab in patients with psoriasis: a 16-week retrospective observational study. [PDF]

Skin Health Dis
Kutlubay Z, Demir Y, Yildirim G, Yildiz B, Diken FZ, Engin B, Serdaroglu S.   +6 more
europepmc   +1 more source

Case Report: Bimekizumab for dissecting cellulitis of the scalp. [PDF]

Front Immunol
Seiter D.
europepmc   +1 more source

Hidradenitis Suppurativa and IL-17 Inhibitors: A Focus on Trials and Real-Life Data. [PDF]

Medicina (Kaunas)
Martora F, Tommasino N, Esposito V, Brescia C, Megna M.   +4 more
europepmc   +1 more source

Comparative Effectiveness of Four Biologics for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. [PDF]

Cureus
Abdullah A, Polus L.
europepmc   +1 more source

Successful Treatment of Refractory Palmoplantar Pustulosis With Bimekizumab in a Patient With Multiple Sclerosis: A Case Report. [PDF]

Cureus
Mahboob O, Acosta-Peñaloza J, Kongala B, Amawi Y, Tie C.   +4 more
europepmc   +1 more source

Refractory acute generalized exanthematous pustulosis-Successfully treated with bimekizumab. [PDF]

JAAD Case Rep
Brand FL, Radonjic-Hoesli S, Schlapbach C.   +2 more
europepmc   +1 more source